Improving women's health after donor stem cell transplant
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at improving health after a stem cell transplant from a donor. It focuses on women's health issues after the transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You are about to receive your first stem cell transplant from a donor (allogeneic).
- The donor can be related, unrelated, or half-matched (haploidentical).
- You must be able to give informed consent and communicate in English or French.
- You are not receiving a second transplant or using your own stem cells.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to prevent graft-versus-host disease (GvHD), a common complication after a stem cell transplant. It is for people with certain blood cancers who are getting a stem cell transplant from a half-matched family member or unrelated donor.
This study looks at how stem cell transplants affect the vagina, especially if you develop a condition called graft-versus-host disease (GVHD). Researchers will examine the vagina and test its natural germs (microbiome) to better understand and possibly improve treatment.
This study looks at immune cells in the blood and tissues of people who have had a stem cell transplant. It aims to understand chronic graft-versus-host disease (GVHD), a common complication, so doctors can better detect and treat it.
This observational study follows people who had a stem cell transplant a few months ago to better understand risk for chronic graft-versus-host disease. You won’t get a study treatment; instead, you’ll complete questionnaires over time, and the study team looks at your symptoms and experiences.
This study looks at heart problems that can happen after a stem cell transplant from a donor (allogeneic). It aims to understand these risks better so doctors can help patients stay healthier after transplant.
This trial tests whether a special probiotic made from the patient's own gut bacteria and their donor's can help fix gut problems caused by a complication called graft-versus-host disease (aGVHD) after a stem cell transplant. It might help patients who are over 50 and scheduled for a specific type of transplant.
Hear when a new GVHD, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.